ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

U.S. Radiologists Criticize Canadian Study Of Mammography Screening Showing No Benefit

November 27, 1992

Tobacco Control: NCI Report Counters View Of Cigar Smoking As Safer Alternative

April 17, 1998

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

In Congress: specer, Harkin Pan re-Introduction Of Research Trust Fund

March 21, 1997